Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000814133-23-000032
Filing Date
2023-02-08
Accepted
2023-02-08 15:46:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 atra223.txt SC 13G 2475
  Complete submission text file 0000814133-23-000032.txt   4025
Mailing Address 505 WAKARA WAY 3RD FLOOR SALT LAKE CITY UT 84108
Business Address 505 WAKARA WAY 3RD FLOOR SALT LAKE CITY UT 84108 8015330777
WASATCH ADVISORS INC (Filed by) CIK: 0000814133 (see all company filings)

EIN.: 870319391 | State of Incorp.: UT | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320
Business Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320 805-623-4244
Atara Biotherapeutics, Inc. (Subject) CIK: 0001604464 (see all company filings)

EIN.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88393 | Film No.: 23598922
SIC: 2836 Biological Products, (No Diagnostic Substances)